장마감
로그인 회원가입
MMED
MMED
MiniMed Group Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$17.67
+0.84 ▲ +4.99%
🌙 7월 27일 6:55 PM ET (한국 7/28 07:55)
$17.91
+0.24 ▲ +1.36%

미니메드 그룹(MMED) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$5.0B
스몰캡
P/E
-
배당수익률
없음
52주 위치
71%
저점 +66% · 고점 -14%
애널리스트
적극 매수
C
Fundamental health
vs. Medical Instruments & Supplies· based on 3 axes
수익성
데이터 부족
성장
Top 46%
밸류에이션
Top 53%
재무 안정
Top 63%
Index RUTP/E -EPS (ttm) -Insider Own 90.76%Shs Outstand 280.8MPerf Week 4.43%
Market Cap 4.96BForward P/E 27.92EPS next Y -0.29%Insider Trans -Shs Float 26.0MPerf Month 24.26%
Enterprise Value 4.72BPEG -EPS next Q 0.1Inst Own 11.59%Short Float 24.44%Perf Quarter 33.86%
Income -P/S -EPS this Y 149.2%Inst Trans 32.65%Short Ratio 6.53Perf Half Y -
Sales -P/B 1.37EPS next 5Y -ROA -Short Interest 6.35MPerf YTD -7.24%
Book/sh 12.86P/C 16.65EPS past 3/5Y -ROE -52W High -13.73% ($20.48)Perf Year -
Cash/sh 1.06P/FCF -Sales past 3/5Y -ROIC -52W Low 65.92% ($10.65)Perf 3Y -
Dividend Est. -EV/EBITDA -EPS Y/Y TTM -Gross Margin -Volatility(W/M) 5.15% 5.93%Perf 5Y -
Dividend TTM -EV/Sales -Sales Y/Y TTM -Oper. Margin -ATR (14) 0.91Perf 10Y -
Dividend Ex-Date -Quick Ratio 1.43EPS Q/Q -Profit Margin -RSI (14) 69.04Recom 1.18
Dividend Gr. 3/5Y -Current Ratio 1.92Sales Q/Q -SMA20 11.56% ($15.84)Beta -Target Price $20.6
Payout -Debt/Eq 0.01Earnings 2026/6/3SMA50 23.99% ($14.25)Rel Volume 1.97Prev Close $16.83
Employees 8000LT Debt/Eq 0.01EPS/Sales Surpr. -356.07% 1.01%SMA200 23.59% ($14.3)Avg Volume(3M) 0.97MPrice $17.67
IPO 2026/3/6Option/Short Yes/YesTrades 10661Volume 1,915,688Change 4.99%
Quarterly earnings trend SEC filings · USD
24.7
24.10
25.1
25.7
25.10
26.1
Revenue Net income 최근 분기: 매출 $790M (YoY +15%) · 순이익 $-119M (YoY -1090%)

📊 MiniMed Group Inc (MMED) Investment Analysis

What kind of company is MiniMed Group Inc?

미니메드 그룹(MMED)
Healthcare · Medical Instruments & Supplies
#1404 by Market Cap — Mid-Cap

💉 A medical device company that provides diabetes management devices. It offers a diabetes management ecosystem including automated insulin pumps, continuous glucose monitors, and smart insulin pens, and was spun off from Medtronic before going public. The company is a diabetes device specialist equipped with an automated insulin delivery system.

Learn more about MiniMed Group Inc →
Market Cap
$5.0B
Approx. KRW 6.8 trillion
⚖️ 2% of Samsung Electronics
Market Cap Rank1404
Employees8,000people
IPO2026/03/06
Current Price$17.67 ≈ 24,208원
📌 RUT · NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 6월 3일 (수) · 장 시작 전 EPS -356.1% 매출 +1.0%

Is it profitable?

Financial health solid
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.01
✓ Very low debt
My positionTop 5%
Low range Average High range
Medical Instruments & Supplies Median 0.26
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.92
✓ 양호
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 2.34
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.43
✓ 양호
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 1.97
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$20.60
현재가 대비 +16.6%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
27.92배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
내년 EPS 예상 성장률
-0.3%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Volatility
Frequently misses analyst estimates
0
예상 상회
0
예상 부합
1
예상 하회
0%
상회 비율
-356.1%
평균 서프라이즈
2026.06.03
하회
-356.1%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth
Mid-range within the industry
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+149.2%
우수
My positionTop 25%
Low range Average High range
미분류 중형주 Median 7.3% · Top 14%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
-0.3%
부진
My positionBottom 25%
Low range Average High range
미분류 중형주 Median 15.6% · Bottom 22%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Returns by period
Current position within 52-week range
Low (-65.9%p) High (-13.7%p)
Current price is 65.9% above the 52-week low and 13.7% below the 52-week high
Recent risk (last 98 trading days)
Max drawdown
-41.6%
Annualized volatility
60.6%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 98-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

⚠️
Current diagnosis · 2026-07-27
Overbought zone — short-term pullback possible

Current price $17.67 broke above the upper band ($17.46). Stronger buying than average, but signals short-term overheating. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟢
Current diagnosis · 2026-07-27
Bullish momentum holding

MACD 0.735 > Signal 0.637 in positive zone + Hist positive (+0.098). Trend in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-27
Bullish zone

RSI 69.1 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 97.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average
Cheap on Vs. Assets, In line with peers on Vs. Earnings
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Mid-range
🏢 Vs. Assets Cheap
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
27.92x
✓ Fair
My positionMid-range
Low range Average High range
Medical Instruments & Supplies median 18.44x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
1.37x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Instruments & Supplies median 2.71x · Top 22% — relatively cheap within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
Analyst target price (reference)
$20.60 vs. current price +16.6%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Instruments & Supplies

Who owns it?

Ownership flow shows some pressure
Institutional net buying +32.6% · Short interest very high 24.4% · Short interest up +14.2pp over last 63d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
+32.6%
Institutions large net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 11.6%
Retail-led
Healthcare 중형주 Median 89.4%
🧑‍💼 Insiders 90.8%
Founder/management large holders (strong skin-in-the-game)
Healthcare 중형주 Median 9.4%
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
24.4%
Very high — strong short-side pressure
Healthcare 중형주 Median 11.3%
Past 63 days 📈 +14.2%p increase
Short interest days to cover
6.5 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 280.8M주
Float (tradable shares) 26.0M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 63 days.

ETFs holding MMED

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
MMED MMED This Stock
$5.0B- 1.4 - - +5.0%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 미니메드 그룹(MMED)?

미니메드 그룹(MMED) belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is the market cap of MMED?

The market cap of MMED is approximately $5.0B, ranking 1,404 within its sector.

What is the 52-week high and low for MMED?

MMED has recorded a 52-week high of $20.48 and a low of $10.65.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.